AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Amedisys Inc. (AMED)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

91.21

-1.40 (-1.51%)

At close: Feb 20, 2025, 3:59 PM

91.09

-0.13%

After-hours: Feb 20, 2025, 04:01 PM EST

undefined% (undefined)

Bid	91
Market Cap	2.99B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	2.52
PE Ratio (ttm)	36.19
Forward PE	n/a
Analyst	Hold

Ask	93.88
Volume	899,834
Avg. Volume (20D)	441,642
Open	91.50
Previous Close	92.61
Day's Range	90.50 - 92.01
52-Week Range	82.15 - 98.95
Beta	undefined

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Aug 17, 1994

Employees 19,000

Stock Exchange NASDAQ

Ticker Symbol AMED

Website https://www.amedisys.com

Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $101, which is an increase of 10.73% from the latest price.

Buy 16.67%

Hold 83.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Amedisys Inc. is scheduled to release its earnings on Mar 4, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+4.67%

Amedisys shares are trading higher after the compa... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Amedisys (AMED) Earnings Expected to Grow: Should You Buy?

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago · marketbeat.com

3 Stocks to Gain From Trump's Family Caregiver Tax Credits

President Trump has endorsed the passage of a tax credit for family caregivers. The tax credit would be given to caregivers who take care of a parent, family member, or a loved one.

1 month ago · zacks.com

UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through

UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.

1 month ago · zacks.com

Reasons to Retain AMED Stock in Your Portfolio Now

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

1 month ago · https://www.proactiveinvestors.com

Midnight Sun Mining secures Kazhiba target license renewal - ICYMI

Midnight Sun Mining Corp (TSX-V:MMA, OTCQB:MDNGF) director of marketing and communications Adrian O'Brien talked with Proactive about securing approval from Zambia's Mines Ministry for the renewal of ...

1 month ago · https://www.proactiveinvestors.com

Midnight Sun Mining: illuminating the Zambian-Congo copperbelt with pursuit of high-value deposits

UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) and Amedisys (NASDAQ:AMED) have agreed to extend the deadline for their $3.3 billion merger, facing ongoing scrutiny from the US Department of Justice (DOJ)....

1 month ago · proactiveinvestors.com

UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny

1 month ago · investopedia.com

Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger

UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.

1 month ago · benzinga.com

Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?

Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.